Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis  Davide Martorana, PhD, Francesco Bonatti,

Published byΦυλλίς Μαρής Modified over 5 years ago

Similar presentations

Presentation on theme: "Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis  Davide Martorana, PhD, Francesco Bonatti,"— Presentation transcript:

1 Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis  Davide Martorana, PhD, Francesco Bonatti, PhD, Federico Alberici, MD, Andrea Gioffredi, MD, Michele Reina, PhD, Maria L. Urban, MD, Federica Maritati, MD, Alessia Adorni, PhD, Antonella Radice, PhD, Silvia Pizzolato, MD, Gina Gregorini, MD, Guido Jeannin, MD, Giuseppe Guida, MD, PhD, Monica Boita, PhD, Alberto Pesci, MD, Gabriella Moroni, MD, Tauro M. Neri, MD, Renato A. Sinico, MD, Augusto Vaglio, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 137, Issue 5, Pages e8 (May 2016) DOI: /j.jaci Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig E1 Three representative examples of amplification efficiency plots for CN assays (FCGR3B target and RNaseP reference) calculated with input DNA concentrations of 7 different dilutions ( ng DNA) per reaction. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig E2 Histograms of FCGR3B CNV analysis with the CopyCaller v2.0 program. The software displays 1 bar for each analyzed sample. The y-axis displays the CN for each sample, and the x-axis displays the samples. For example, sample A_01 has 1 copy of FCGR3B, sample A_03 has 2 copies of FCGR3B, and sample A_04 has 3 copies of FCGR3B. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig E3 Distribution of FCGR3B CNs of 1 versus 2 or greater in patients with EGPA and healthy control subjects. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Fig E4 Distribution of each CN of the FCGR3B gene in patients with EGPA and healthy control subjects. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

6 Fig E5 Eosinophil counts in patients with EGPA with FCGR3B CNVs of 1 versus 2 or greater (P = .77). Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

7 Fig E6 C-reactive protein (CRP) levels in patients with EGPA with FCGR3B CNVs of 1 versus 2 or greater (P = .46). Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis  Davide Martorana, PhD, Francesco Bonatti,"

Similar presentations

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,
A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,

A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,
Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,

Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
D-dimer: A biomarker for antihistamine-resistant chronic urticaria

D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Allergen immunotherapy: A practice parameter third update

Allergen immunotherapy: A practice parameter third update
Clarification concerning amoxicillin skin testing

Clarification concerning amoxicillin skin testing
Fatty acids, inflammation, and asthma

Fatty acids, inflammation, and asthma
Airway fibroblasts exhibit a synthetic phenotype in severe asthma

Airway fibroblasts exhibit a synthetic phenotype in severe asthma
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Major rabbit allergen Ory c 3: What could be its possible role as a sensitizing agent in real life?  Gennaro Liccardi, MD, Antonello Salzillo, MD, Maria.

Major rabbit allergen Ory c 3: What could be its possible role as a sensitizing agent in real life?  Gennaro Liccardi, MD, Antonello Salzillo, MD, Maria.
Stephen J. Fowler, MD, Gaël Tavernier, PhD, Robert Niven, MD 

Stephen J. Fowler, MD, Gaël Tavernier, PhD, Robert Niven, MD 
David A. Khan, MD  Journal of Allergy and Clinical Immunology 

David A. Khan, MD  Journal of Allergy and Clinical Immunology 
Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study  John M. Brehm, MD, MPH, Brooke Schuemann, BS,

Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study  John M. Brehm, MD, MPH, Brooke Schuemann, BS,
Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 

Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Desensitization to Chemotherapeutic Agents

Desensitization to Chemotherapeutic Agents
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Fatty acids, inflammation, and asthma

Fatty acids, inflammation, and asthma

Similar presentations

Ads by Google